Mutational analysis of the PTEN gene in human uterine sarcomas
Article Abstract:
Mutations of the PTEN gene do not cause all uterine sarcomas, according to a study that only found a PTEN mutation in two out of 36 tissue samples from women with uterine sarcoma. This type of uterine cancer is rare, making up 5% of all uterine cancers.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Loss of heterozygosity on chromosome 17q11-21 in cancer of women who have both breast and ovarian cancer
Article Abstract:
Inherited abnormalities of the BRCA1 gene appear to be involved in some cases where women develop both breast and ovarian cancer independently. The BRCA1 gene is believed to be an important tumor suppressor gene, but at the time of this investigation, its chromosome was known, but not its precise location. Only indirect investigation of abnormalities within regions of its chromosome could be carried out. Its location has since been pinpointed. Cancerous and normal tissue samples were analyzed from 29 women who developed primary cancers of both breast and ovary. DNA analysis revealed abnormalities of the chromosome containing BRCA1 in 46% of breast cancers, 78% of ovarian cancers, and 38% of both cancers. In all cases where the chromosome was abnormal in both cancers, the same strand of the pair was affected. These cases also tended to be among younger women. These women seem more likely to have an inherited genetic defect.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 1995
User Contributions:
Comment about this article or add new information about this topic:
Role of BRCA1 mutation screening in the management of familial ovarian cancer
Article Abstract:
A screening test to identify the altered gene thought to be responsible for breast and ovarian cancer is now available. This gene is called the BRCA1 susceptibility gene. Research has shown that more than 90% of the women with ovarian cancer who have an immediate family history of ovarian cancer carry the BRCA1 gene. It may be advisable for women who carry this gene to have their ovaries removed as a preventive measure. However, research has not yet identified the best possible course of action for these carriers.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 1996
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Use of alternative medicine by women with early-stage breast cancer. Primary care for survivors of breast cancer
- Abstracts: Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation
- Abstracts: Effect of menstruation and intrapelvic injection of endometrium on inflammatory parameters of peritoneal fluid in the baboon (Papio anubis and Papio cynocephalus)
- Abstracts: The risks of spontaneous preterm delivery and perinatal mortality in relation to size at birth according to fetal versus neonatal growth standards
- Abstracts: A prospective, randomized, controlled trial of high and low maintenance doses of magnesium sulfate for acute tocolysis